Allergies Generic Pharmaceutical Licensing 
XTalks
AUGUST 2, 2023
Late in 2022, AbbVie partnered with HotSpot Therapeutics and announced an exclusive worldwide collaboration and option to license agreement for their interferon regulatory factor 5 (IRF5) inhibitor program for autoimmune disease treatment. In 2022, Bayer’s revenue in the Pharmaceutical and Consumer Health sectors reached $26.68
The Pharma Data
DECEMBER 23, 2020
Aurobindo Pharma Limited (NSE: AUROPHARMA) (BSE: 524804) (Reuters: ARBN.NS) (Bloomberg: ARBP:IN), headquartered at Hyderabad, India , manufactures generic pharmaceuticals and active pharmaceutical ingredients. ” About Aurobindo Pharma. Aurobindo Pharma has several WHO prequalified products.
The Pharma Data
DECEMBER 23, 2020
Under the signed license agreement, Aurobindo Pharma has obtained the exclusive rights to commercialize in India and to UNICEF and non-exclusive rights in other select emerging and developing markets. Partnering with top-tier organizations such as Aurobindo is a crucial step in expanding our global scale, reach and impact.”.
Expert insights. Personalized for you.
98 
Let's personalize your content